Related Experiment Video

Updated: Aug 11, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Expression of lymphocyte function-associated antigen (LFA)-1 in B-cell chronic lymphocytic leukemia

S Woessner1, A Asensio, L Florensa

  • 1Hematology and Oncology Unit 1973, Hospital Central de L'Aliança, Barcelona, Spain.

Leukemia & Lymphoma
|May 1, 1994
PubMed

Insights

Decreased expression of lymphocyte function associated (LFA)-1, an adhesion molecule, is a constant finding in B-cell chronic lymphocytic leukemia (B-CLL). This decrease may help distinguish B-CLL from reactive lymphocytosis.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Lymphocyte function associated (LFA)-1 is a critical adhesion molecule involved in immune cell interactions.
  • B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous lymphoproliferative disorder.
  • Understanding molecular markers in B-CLL can aid in diagnosis and management.

Purpose of the Study:

  • To investigate the expression levels of LFA-1 (CD11a/CD18) in patients with B-CLL.
  • To determine if LFA-1 expression correlates with clinical staging (Rai stages) in B-CLL.
  • To evaluate the potential utility of LFA-1 expression in differentiating B-CLL from reactive lymphocytosis.

Main Methods:

  • Flow cytometry was used to analyze the expression of CD11a and CD18 on lymphocytes.
  • The study included 53 patients diagnosed with B-CLL and 37 healthy controls.
  • Statistical analysis was performed to compare LFA-1 expression between groups and clinical stages.

Main Results:

  • Significantly lower expression of CD11a (mean 14.2%) and CD18 (mean 14.8%) was observed in B-CLL patients compared to controls (CD11a 92%, CD18 90%) (p < 0.001).
  • No significant correlation was found between CD11a/CD18 expression levels and the Rai clinical stages of B-CLL.
  • A consistent decrease in LFA-1 expression was noted in early-stage B-CLL.

Conclusions:

  • Reduced LFA-1 expression is a characteristic finding in B-CLL, even in early disease stages.
  • LFA-1 expression levels may serve as a valuable biomarker for distinguishing B-CLL from reactive increases in lymphocytes.
  • Further research could explore LFA-1 as a diagnostic or prognostic indicator in B-CLL.

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Related Concept Videos

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...